1. Home
  2. HDL vs PCRX Comparison

HDL vs PCRX Comparison

Compare HDL & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HDL

SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

N/A

Current Price

$16.46

Market Cap

0.0

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$23.57

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HDL
PCRX
Founded
2016
2006
Country
Singapore
United States
Employees
13651
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
HDL
PCRX
Price
$16.46
$23.57
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$37.60
AVG Volume (30 Days)
835.0
744.5K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.16
Revenue
N/A
$541,533,000.00
Revenue This Year
$10.47
$9.77
Revenue Next Year
$14.04
$9.71
P/E Ratio
$55.56
$142.69
Revenue Growth
N/A
26.04
52 Week Low
$15.83
$18.80
52 Week High
$28.88
$27.99

Technical Indicators

Market Signals
Indicator
HDL
PCRX
Relative Strength Index (RSI) 47.07 59.03
Support Level $16.08 $23.10
Resistance Level $16.99 $23.82
Average True Range (ATR) 0.23 1.07
MACD -0.06 0.09
Stochastic Oscillator 20.61 95.14

Price Performance

Historical Comparison
HDL
PCRX

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: